At the time of writing, PMV Pharmaceuticals Inc [PMVP] stock is trading at $1.73, up 7.45%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PMVP shares have gain 5.81% over the last week, with a monthly amount glided 0.58%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
PMV Pharmaceuticals Inc [NASDAQ: PMVP] stock has seen the most recent analyst activity on April 12, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $5. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on December 27, 2023, and set its price target to $7. On March 02, 2022, upgrade upgraded it’s rating to Outperform but maintained its price target of $30 on the stock. Goldman upgraded its rating to a Buy and increased its price target to $43 on September 22, 2021. Oppenheimer initiated its recommendation with a Perform. Guggenheim started tracking with a Buy rating for this stock on August 02, 2021, and assigned it a price target of $56. In a note dated July 29, 2021, H.C. Wainwright initiated an Buy rating and provided a target price of $63 on this stock.
For the past year, the stock price of PMV Pharmaceuticals Inc fluctuated between $1.17 and $9.72. Currently, Wall Street analysts expect the stock to reach $24.75 within the next 12 months. PMV Pharmaceuticals Inc [NASDAQ: PMVP] shares were valued at $1.73 at the most recent close of the market. An investor can expect a potential return of 1330.64% based on the average PMVP price forecast.
Analyzing the PMVP fundamentals
Gross Profit Margin for this corporation currently stands at 0.28% with Operating Profit Margin at -49.53%, Pretax Profit Margin comes in at -42.62%, and Net Profit Margin reading is -41.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.26, Equity is -0.29 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6350 points at the first support level, and at 1.5400 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7900, and for the 2nd resistance point, it is at 1.8500.
Ratios To Look Out For
It is important to note that PMV Pharmaceuticals Inc [NASDAQ:PMVP] has a current ratio of 14.78. As well, the Quick Ratio is 14.78, while the Cash Ratio is 2.75.
Transactions by insiders
Recent insider trading involved ORBIMED ADVISORS LLC, 10% Owner, that happened on Nov 22 ’23 when 87786.0 shares were sold. Chief Medical Officer, Alland Leila completed a deal on Sep 15 ’23 to sell 6291.0 shares. Meanwhile, Chief Development Officer Jalota Deepika sold 4104.0 shares on Sep 15 ’23.
